important considerations in the management of hr , her2-negative early breast cancer
Published 1 year ago • 6.3K plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
4:45
advances and considerations in the treatment and management of hr , her2-, advanced breast cancer
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
34:58
management of hr-positive/her2-negative early breast cancer: taking direction from the updated gu...
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
46:25
the role of biomarkers in hr-positive/her2-negative early breast cancer: from clinical analysis t...
-
54:38
what is the relationship between estrogen and breast cancer? | dr. avrum bluming
-
33:34
sharing my her2 breast cancer diagnosis story at 35 years old
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
33:11
recent updates in hr-positive/her2-negative early breast cancer: a deep dive into understanding t...
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
31:59
assessing risk in hormone receptor-positive/her2-negative early breast cancer: how to approach ch...
-
31:07
recent advances in the treatment of hr positive, her2 negative metastatic breast cancer
-
2:14
management of premenopausal hr /her2- breast cancer with micro-metastasis
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
0:57
evaluating the benefits of selective cdk4 inhibition in hr /her2- breast cancer
-
15:00
new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
-
0:56
remaining questions on the management of her2-low breast cancer
-
28:25
managing the borderline-risk patient with hormone receptor-positive/her2-negative early breast ca...
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices